AUCTORES
Globalize your Research
Review Article
*Corresponding Author: Ron Batash, Orthopedic Oncology unit, University hospital of Padova, Padova, Italy.
Citation: Moshe Schaffer, Ron Batash, Pamella M. Schaffer, Murad Asali, Tom Zuckerman, et al, (2024), The Role of Photosensitizers as Radiosensitizers in Cancer Treatment, J. General Medicine and Clinical Practice, 7(5); DOI:10.31579/2639-4162/155
Copyright: © 2024, Ron Batash. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Received: 02 March 2024 | Accepted: 11 March 2024 | Published: 26 March 2024
Keywords: photosensitizers; radiosensitizers; radiotherapy; cancer therapy; cancer relapse
Enhanced cancer resistance to treatment is associated with various mechanisms. However, cancer may frequently relapse after some time. Several strategies have emerged over the last few years to halt this process - improving cancer therapy, including - chemotherapy, radiotherapy, immunotherapy, surgery, targeted therapy, hormone therapy, stem cell transplant, and precision medicine. Among those strategies, Radiotherapy (RT) is an essential modality to treat tumors and control their growth. Tumors can withstand more ionizing radiation than normal tissue. However, the addition of radiosensitizers can adjust the effect of the radiation on tumors tissues, causing significant damage to the neoplastic tissue. PDT (photodynamic therapy) was considered a promising treatment for early and localized inoperable tumors. This work provides combination therapy comprising a radio sensitizing agent and radiation therapy, describing its effectiveness in inhibiting the proliferation of cancer cells and cancer stem cells, including mechanism of function (partially known) and the possibility of using this method as a kind of targeting therapy.
New challenges in cancer therapy have emerged recently, considering enhanced resistance to conventional treatment of various cancer types. Moreover, high incidences of relapse after primary cancer regression contribute to the problem. Enhanced cancer resistance to treatment is associated with multiple mechanisms, including mutations and drug over- expression of the drug-target. Other mechanisms involve drug termination from the cells or inactivation of the drug. Several strategies have been attempted over the last few years, in order to improve cancer therapy and reduce mortality. The methods include - radiotherapy, immunotherapy, surgery, targeted therapy, hormone therapy, stem cell transplant and precision medicine. Among these strategies, Radiotherapy (RT) is an essential modality to treat tumors and hinder their growth [1-3]. As widely described in the literature, cancer lesions are comprised of a heterogeneous population of cells, which include numerous types. This may be one of the causes for failure of treatment and cancer relapse. Several cancer resistance and recurrence models have been associated with small populations of identified cancer stem cells. For instance, malignancies of hematopoietic origin and some solid cancers. Such cells are also considered cancer stem cells (CSCs) or cancer-initiating cells. These cells have self- renewal capabilities and therefore, are a fundamental concept in tumor biology4,5. Their ability to initiate tumor growth granted them the name - “tumor-initiating cells” (TICs)5. Tumor-initiating cells are phenotypically different from their fellow tumor cells, since they express explicit markers and functional features, such as resistance to conventional therapy [6-8]. TIC express organ-specific markers and characteristics that separate them from differentiated cells, e.g., expression of active DNA repair ability, expression of specific ABC drug transporters and disinclination to apoptosis signals. In clinical terms, the stem cell model for relapse may be highly suitable for chemotherapy responding cancers with a complete response, that relapse months or years later [9,10]. One explanation for the failure of conventional cancer therapy might be the presence of CTC, reflecting the need to identify new therapies to target those cells. Currently, there are various modalities for treating cancer, including a combination of radiation and a radio- sensitizing agent, which have been shown to enhance therapy [4,5,9-11]. Several radiosensitizers were depicted, partly in clinical use and partly experimental, such as small molecules and various chemotherapies, e.g., oxygen, oxygen mimics, hypoxia-specific cytotoxins, cisplatin, 5FU, nanoparticles, and photosensitizers. While considered high for tumors compared to normal tissue, the ability to withstand ionizing radiation can be adjusted by computer-controlled irradiation protocols with different radiation frequencies. [9,10,12-14].
Moreover, the tumor tissue selection to radiation is enhanced by radiosensitizers; which can be used to achieve a more significant rate of deterioration of the neoplastic tissue, as opposed to the additive effect of each modality [9,10]. When using radiosensitizers, one must consider two main parameters: possible complications of use and the therapeutic ratio - the likelihood of local tumor control. Most of the commonly utilized radiosensitizers are not tumor-specific and have poor selectivity. Usage of such compounds can potentially lead to severe complications as a result of their toxicity. Hence, an ongoing search for specific radiosensitizers has begun, as a means to improving the outcome of radiation therapy on relatively radio-resistant hypoxic tumor cells9,10
PDT (photodynamic therapy) was estimated to have promising results in treating early and localized inoperable tumors in the 1980s [15,16]. The technique involves a topical or systemic administration of a photosensitizer and the exposure of the tumors to a specific wavelength absorbed by the photosensitizer [15,16].
Due to their tetrapyrrolic macrocycle, the preferred photosensitizers are the porphyrins, and their equivalents, with absorption bands in the 600-800 nm wavelength (the red region of the visible spectrum) that enables high penetration into human tissue [8,16,17].
The PDT effects result from a reaction between the photosensitizer's initially formed excited singlet state and the photosensitizer's lowest triplet state, having an intersystem crossing [15-17]. Consequently, this triplet photosensitizer and the biological targets can interact with the transfer of electron or proton, generating the construction of radical particles that in turn, form oxidized products after interaction with oxygen – a process known as type I reaction [18-20].
Alternatively, the energy from the metabolite might be transferred to molecular oxygen directly, causing singlet oxygen to form. The singlet oxygen is cytotoxic, and the mechanism is called a type II reaction19. In both types of reactions, the presence of oxygen is crucial21,22. In contrast to ionizing radiation, which primarily targets cellular DNA, PDT is known to affect cellular membranes, blood vessels and mitochondria [16,23].
This paper aims to review the use of photosensitizers as selective and specific radiosensitizers. Due to the fact that there is a vast number of existing Photosensitizers, which can be used as radiosensitizers, we tried to focus mainly on main photo-radio-sensitizers. We are presenting a combination therapy technique, comprising of radio sensitizing agent and radiation therapy, which effectively inhibits the proliferation of cancer cells and cancer stem cells.
Photosensitizer as Radiosensitizer in Vitro and in Vivo
Photosensitizers' selectivity for tumor tissues encouraged the search for the potential use of compounds as radiosensitizers. In 1955 Schwartz et al. conducted experiments showing the radio sensitizing effects of porphyrins in patients taking HpD with radiation therapy [24,25].
The experiment showed enhanced local tumor control in patients with carcinoid tumors, fibrosarcoma, squamous cell carcinoma, and rhabdomyosarcoma [24]. In his publication, the side effects mentioned were vomiting, nausea, and remarked skin photosensitivity that lasted for several months [24]. The metabolic product is HpD, a highly heterogeneous Hp chemical derivative in a chemical reaction between acetic and sulfuric acid with hematoporphyrin. One of the partly purified forms of HpD is Photofrin II [24]. In 1960, Schwartz and Cohen demonstrated that higher doses of hematoporphyrin copper complex facilitate radioprotection, in contrast to smaller amounts, which showed a noticeable radio sensitizing effect. In 1986, Kostron et al. managed to reduce 40% of rat glioma tumor growth compared to the control group, which confirmed the radio sensitizing potential of HpD (Hemato-porphyrine derivative) [26]. One of the derivatives of perylenequinonea product of the plant Hypericum perforatum, which is used for treatment, is the red-colored Hypericin (St. John's wort) [27].
Hypericin and its derivatives have been studied for their physicochemical properties, e.g., electron transfer, singlet-oxygen sensitization, and excited- state proton transfer [28,29]. Moreover, Hypericin is an antidepressant, antiviral agent, and potent protein kinase C inhibitor, enabling tumor selectivity and specificity in photodynamic therapy [30,31]. This fact led to further studies of Hypericin as a diagnostic tool in several cancers, which induced apoptosis in tumor cells [30-33].
A study published in 2015 by Schaffer et al. [34] showed that perylenequinone derivatives (PDs) acted as potent radiosensitizers. This group proved the effects of some derivatives of Hyperecin (PDs) on tumor- initiating cells (TICs) and normal tumor cells [34]. TICs are phenotypically different from other tumor cells due to the expression of specific markers and stem functional cell characteristics, which enable resistance to conventional therapy [8,35,36]. In their study, the group checked TIC cells of PANC1 (pancreas cancer), U87 (glioblastoma), HT29 (colon cancer), MCF7 (breast cancer), A549 (lung cancer) tumor cell lines. Cells in culture were given 0.1- 2M of Hypericin tetrasulfonate (HyTS), Tetrabromo hypericin (TBrHy,) or PDs Hypericin (Hy), followed by illumination with fractionated daily dose or single high dose of radiation, then, the cell viability was assessed. Additionally, the researchers assessed the tumor development of PANC1 and U87 cells in subsequently injected PDs mice and illuminated with local ionizing radiation.
Their final findings indicated that PDs expressively hindered the viability of the tumor cells exposed to radiation and grown in the TIC-enriched culture. Furthermore, TBrHy considerably stalled PANC1 and U87 tumor development in mice exposed to high levels of radiation. These findings showed that TIC viability might be used to assess radio sensitizing activity. Therefore, PDs might be considered adequate radiosensitizers, which can mark tumor cells and TICs, underlining substantial therapeutic value [34].
Photofrin II, which is made of porphyrins, synthesized by treating heorphyrin (Hp) with acid, represents one of the backbones of clinical PDT [37]. In 2001, Schaffer et al. aimed to improve the application of Photofrin II as a radiosensitizer in ionizing radiation [38,39]. In one of the studies, human cell bladder cancer (RT4) implanted mice [40] exhibited a nearly 50% reduction in tumor growth after 12 days and X-ray irradiation (5 Gy) 24 hours after injection of Photofrin II. Compared to 5-ALA, chlorin e6, Hp, and Zn- tetrasulfophtalocyanine, Photofrin II was the only photosensitizer that showed a significant change - “doubling time” of the tumor, that changed from 6.2 days to 10.9 days. However, the mechanism responsible for the positive effect remains vague due to Photofrin's heterogeneous composition. While 5-ALA with X-ray irradiation (3 Gy) was inefficient in mice with Lewis’s sarcoma tumors implanted in them, Photofrin led to a nearly 40
Results are shown in Table 2
[58]. Due to the light sensibility by photosensitizers, especially photofrin II, the patients were protected from light during their treatment for a period of 3-4 weeks. All lights indoors were limited with lamps of 40W. Two of these patients with advanced tumors, one female with Astrocytoma Grade III and another female with Cervix Carcinoma FIGO IIIb, are still alive and currently free of disease [60,61].
The literature review and demonstrated results illustrate that PS might be utilized as a radio sensitizing agent in the right circumstances. While PS on its own showed no noticeable tumor response in concentrations that presenteda marked radio sensitizing effect, the radiosensitizing effect it has can be confirmed in highly radio resistant tumor models, such as bladder carcinoma and glioblastoma [34,55,58,60,61].
As a general rule, radiosensitizers imitatethe effects of oxygen caused by free radicals in radiationtherapy. Nitroimidazole is the most common radiosensitizer evaluated in clinical studies. A significant drawback of this agent lies in its neurotoxicity, which prevented using an effectual dose with a standard daily fractionated radiation [54,62]. Other compounds, for example, Tirapazamine[63,64], bovine hemoglobin modified with polyethylene glycol (PEG)[65], and RSR [13,66], are currently in the clinical investigation for hypoxic tumor cells. The direct consequence of radiation (RT) is to cause double-strand breaks (DSB) and single-strand breaks (SSB) in DNA. The breaking of the DNA leads to the termination of cell divisionand cell proliferation, and in some cases, to cell necrosisand cell apoptosis. See figure1a.[24,25,26,34,38]
The indirect consequences of radiation lead to the generation of reactivity of Oxygen Radicals such as RO; ROS might cause cellular stress, induce biomolecules damage and eventually change the cellular signaling pathways. A number of studies demonstrated that 70% of the patients should be treated with controlled linear accelerators to carry the specific radiation quantities to the malignanttumor or the selected areas inside the tumor tissue [51,62,67,68].
Although these advanced developments increase the therapeutic results,hurdles still exist - cancer stem cells and tumor heterogeneity, limiting the use of RT alone as an ns of tumor eradication. However, by utilizing radiosensitizers that enhance the radiosensitivity of the tumor tissue and have toxicity within the range of pharmacologically normal tissue, one can apply RT more effectively and achieve the desired outcome [62,67,69].
When combined with radiation, radiosensitizers demonstrate higher tumor inactivation than predicted from the particular singular modalities [69,70]. The mechanisms of action of radiosensitizers can be classified into five different steps: (1) blocking the radioprotective effect of intracellular thiols or other endogenous substances; (2) generation of cytotoxic agents by radiosensitizer radiolysis; (3) inhibition of biomolecules repair; (4) thymine analogs incorporation into DNA; and (5) electrophilic activityof oxygen mimickers [9,70]. According to recently published studies, radiosensitizers can be categorized into three differentclasses, based on their molecularstructure: little molecules, e.g., oxygen Mimics [5,70],
macromolecules, e.g., Proteins and Peptides, and Oligonucleotides [67,68]. The last group is nanomaterials, e.g., metal and ferrite nanomaterials [69,70]. Junzhi Liu, et al. [70], found that acridine orange (AO), a small molecule radiosensitizer, can be loaded onto mMnO2 nanoparticles at very high efficiency and released to the surroundings in a controlled fashion. This review has focused on PS as radiosensitizers, which belongs to the second group. Not all commercially available PS evaluated can perform as a radiosensitizer. Furthermore, it appears to be utilizedonly as a photosensitizing agent [34,55].
As mentioned previously in this review, a number of hypotheses aim to showcase the PS radiosensitization of tumors: i) PS has a reaction with molecules that have been activated by cytotoxin, e.g., hydroxyl, radicals that are the productsof the interaction of X-raysand water [10,41,42,49,51,56]. PS reduces the chancesof starting repair processes that prevent radio- induced cell damage [41,50]. The damage that Ionizing irradiation causes split into two categories62: sublethaldamage and lethal damage. The sublethal damage might become lethal or excite the cell mechanisms of repair; the use of Photofrin might minimize the effects of those mechanisms if used in addition to ionizingradiation.
The radiosensitizing ability of PS is a subject of interest for several reasons, regardless of its actual course of action. PS is clinically approved in large amountsin Photodynamic Therapyof cancer. Hence, its use as a radiotherapeutic substance is derived from the ability to avoid, or at least significantly reduce expensive toxicological studies. PS has demonstrated no toxicity in humans at the doses used in radiotherapy [11,17,18,72] and showed certain selectivity of tumor targeting. This is stated in comparison to a number of radiosensitizers in clinical uses that have a much lower tumor targetingand demonstrate harsh side effectsin in vivo settings [15,62].
PS's ability to be utilized as a phototherapeutic and a radiotherapeutic substance provides extraordinary insights on its mechanisms, and enables superior regulation of tumor growth. However, various PS cause skin photosensitization (depends on the type of PS) that might hinder the use of this agent, while radiation therapy is considered. This is also true for the practice of boost irradiation, HDR following loading irradiation, brachytherapy, or only high precision radiation therapy [37-40]. The standard radiation dose in these modalities is ranged in ranges 2-16 Gy, which is administered to the tumor in a limited time and deprived of loco-regional irradiation. In vivo and vitro studies demonstrated that PS can be utilized in cases of tumor tissue hypoxia and can be considered an effectual radiosensitizer [7,37-41,55,56,73].
The combination of PS with a known contrast media - Gadolinium or with Manganese-dipyriddoxyl-5`diphosphate(Mn-DPDP – might be looked at in searchof diagnostic and treatment methods [71,74].
Conclusion
We believe that PS could potentially become a symbol for helpful agents in managing tumors and demonstrate: i) Better efficacy of radiation on the tumor alone, leaving the radiation effects on the neighboring tissues unchanged. ii) Enhancement of mechanisms that hinder hypoxic cells. iii) Minor toxicity in humans.
Moshe Schaffer and Ron Batash– initiated the study, contributed to its conception, design and writing of the manuscript.
Pamella Schaffer and Alfons Hofstetter designed and performed part of the experiments in the review.
Alejandro Livoff, Murad Asali and Tom Zuckermann contributed to the clinical data and review of the literature.
All authors reviewed and agreed on the manuscript.
All authors state that there are no conflicts of interest.
We wish to express our gratitude to Prof. Giulio Jori, who is considered among the leading pioneers in the field of radiosensitizers and photodynamic therapy.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
